Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Market & Industry Briefs

Executive Summary

Brief summaries of recent medtech market and industry developments. This month we cover new clinical data on TAVI, declining CABG rates in US hospitals, and results from the CATT study comparing Lucentis and Avastin.

You may also be interested in...



Retinal Disease: Much Progress, Some Pain

On many fronts, 2011 was an event-filled year for the retinal disease market, beginning with the publication of the CATT trial comparing off-label intravitreal Avastin versus Lucentis for the treatment of AMD, and ending with several important milestones for device manufacturers operating in this space. But while the retinal device field is making progress in many areas, companies continue to struggle to meet shifting FDA approval requirements.

Start-Up News

Noteworthy news from medtech start-ups. This month's feature, "TAVI Halo Shines on Embolic Protection Devices," first appeared in the May 2011 issue of Start-Up.

Start-Up News

Noteworthy news from medtech start-ups. This month's feature, "TAVI Halo Shines on Embolic Protection Devices," first appeared in the May 2011 issue of Start-Up.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT035429

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel